FIERCE PHARMA ENGAGE
LIVE

Serial Number

99768654

Owner

Questex, LLC

Attorney

Deborah J. Peckham

First Use Date

Apr 29, 2025

Filing Date

Apr 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

FIERCE PHARMA ENGAGE Trademark

Serial Number: 99768654

FIERCE PHARMA ENGAGE is a trademark filed by Questex, LLC on April 16, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Questex, LLC (4 trademarks)

1111B S Governors Ave STE 25792
Dover, DE 19904

Entity Type: 16

Trademark Details

Filing Date

April 16, 2026

Registration Date

Not Registered

First Use Anywhere

April 29, 2025

First Use in Commerce

April 29, 2025

Goods & Services

Downloadable software in the nature of a mobile application used for networking at events for social media and for obtaining news and information in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations

Arranging and conducting trade shows, forums, meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations

Conducting, arranging, promoting and organizing trade shows, business conferences, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 16, 2026 MAFR
NEW APPLICATION ENTERED
Apr 16, 2026 NWAP